جستجوی استاد راهنمای دانشگاهی

Anja Grothمشاهده پروفایل

استاد

• Molecular Cell Biology
• Epigenetics
• DNA Repair
• +۳ مورد دیگر

Anja Groth, 43 years old, is a full professor at the Biotech Research and Innovation Centre (BRIC) under the University of Copenhagen's Faculty of Health Sciences. Her research centers on molecular cell biology, epigenetics, DNA repair, and genome stability, with significant contributions to understanding how cells maintain functional memory during division—a critical process for both human development and cancer progression. Education: MSc in Biochemistry, University of Copenhagen PhD in Cancer Biology, University of Copenhagen (2004) Postdoc at Institut Curie, Paris (3 years) Her groundbreaking work on DNA repair mechanisms revealed a protein critical for cancer cell survival through error-free DNA repair. This discovery is paving the way for novel cancer therapies that block this protein. Using advanced molecular biology and interdisciplinary collaboration, she has published in top journals like Nature and secured two major ERC grants. Key Research Themes: Epigenetic memory and chromatin replication DNA damage repair pathways Histone dynamics and inheritance Replication fork stability Protein networks in genome maintenance Articles show a consistent focus on histone chaperones, ubiquitination pathways, and chromatin assembly factors. Her 2016 discovery of H4K20me0 marks and the TONSL–MMS22L complex has had lasting impacts on DNA repair research. Awards & Grants: EliteForsk Award (2018) EMBO Investigator Heirloom Award for Women Scientist Leaders ERC Starting Grant ERC Consolidator Grant As leader of a diverse research group of 15 international scientists (primarily women), Groth emphasizes collaborative innovation and trust-building in scientific environments. She advocates for sustainable lab practices and flexible research strategies that allow unexpected discoveries.

Joseph A. Baurمشاهده پروفایل

دانشیار

• Aging Biology
• NAD Metabolism
• Mitochondrial Function
• +۵ مورد دیگر

Joseph A. Baur, Ph.D. is an Associate Professor of Physiology at the Perelman School of Medicine, University of Pennsylvania. His research is centered within the Department of Physiology and the Institute for Diabetes, Obesity, and Metabolism, where he leads the Baur Lab focused on aging biology and metabolic regulation. Dr. Baur's research primarily investigates the fundamental mechanisms of aging, with a special emphasis on nicotinamide adenine dinucleotide (NAD) metabolism and its role in age-related diseases. His laboratory employs genetic models, isotopic labeling strategies, and metabolomics to probe NAD synthesis pathways and the effects of supplemental NAD precursors. A key area of investigation is understanding how caloric restriction delays aging and how rapamycin affects metabolism, particularly its impact on lipid and glucose homeostasis. His work has significant implications for understanding and potentially treating age-related conditions including cardiovascular disease, diabetes, cancer, and neurodegenerative disorders. Analysis of Dr. Baur's recent publications reveals a strong focus on NAD metabolism across multiple organ systems, with particular attention to cardiac function, brain metabolism, and mitochondrial dynamics. His research demonstrates how NAD depletion contributes to age-related pathologies and how NAD precursors might serve as therapeutic interventions. The work spans from basic molecular mechanisms to translational applications in disease models. Dr. Baur has made significant contributions to our understanding of how NAD compartmentalization influences fuel selection and circadian variations in metabolism, particularly within mitochondria. His research has helped establish connections between NAD metabolism, aging, and multiple disease states, positioning his work at the forefront of geroscience. The Baur Lab is actively engaged in multiple collaborative projects investigating NAD metabolism in various contexts, including cardiac function, brain energetics, immune cell regulation, and metabolic diseases. Their research continues to uncover novel mechanisms by which NAD homeostasis influences healthspan and disease progression.

Daniel W. Belskyمشاهده پروفایل

دانشیار

• Aging
• Health Disparities
• Genomics
• +۵ مورد دیگر

Daniel W. Belsky is an Associate Professor of Epidemiology at Columbia University's Mailman School of Public Health and a member of the Robert N. Butler Columbia Aging Center. He previously served as an Assistant Professor at Duke University School of Medicine. Education: BA, Swarthmore College (2002) PhD, UNC Gillings School of Public Health (2012) Dr. Belsky's interdisciplinary research integrates genomics , epidemiology , and social sciences to study mechanisms of biological aging and health inequality . His work develops DNA methylation biomarkers like DunedinPACE to quantify aging processes across the lifespan. Recent publications analyze Epigenetic impacts of caloric restriction (CALERIE™ Trial) Transgenerational effects of prenatal famine on aging Socioeconomic determinants of biological age acceleration His 2025 Nature Aging study on aging biomarker validation was cited in 162 papers. Scientific Recognition: ISI Highly Cited Researcher CIFAR Fellow Jacobs Foundation Awardee National Institute on Aging Scholar Current Research: Dr. Belsky leads NIH-funded R01 projects on cash transfers and policy interventions to slow aging. He collaborates with labs in psychology, genetics, and public policy on cross-disciplinary geroscience initiatives.

Kristen L. Zuloagaمشاهده پروفایل

استاد

• Neuroscience
• Alzheimer's Disease
• Neurovascular Biology
• +۷ مورد دیگر

Kristen L. Zuloaga, PhD is a Professor and Director of Graduate Studies in the Neuroscience and Experimental Therapeutics department at Albany Medical College . Her research focuses on understanding how sex, aging, and sex hormones influence vascular and metabolic contributions to dementia, with a particular emphasis on developing sex-specific therapeutic strategies to improve cognitive function. Dr. Zuloaga's work integrates neurovascular biology , endocrinology , and neuroimmunology to address sex differences in Alzheimer's disease and vascular cognitive impairment. 2017 Postdoctoral Fellowship, Neural Stem Cell Institute 2014 Postdoctoral Fellowship, Colorado State University 2011 PhD, Oregon Health & Science University Her recent publications highlight collaborations in sex-specific neuroinflammatory responses , metabolic-neurological interactions , and neuroprotective hormone therapies . Key findings demonstrate how menopause and high-fat diets synergistically impair cognition in mouse models, with distinct vascular and metabolic mechanisms. Scientific awards include major NIH grants ($4M and $8M) supporting research into age-related neurological diseases . She leads the Zuloaga Lab , which investigates the intersection of hormonal transitions , metabolic health , and cerebrovascular function in dementia pathogenesis.

• Geroscience
• Neurodegeneration
• Mitochondrial biology
• +۷ مورد دیگر

Jeremy Van Raamsdonk is an Associate Professor in the Department of Neurology and Neurosurgery at McGill University and a Scientist in the Metabolic Disorders and Complications Program at the Research Institute of the McGill University Health Centre (RI-MUHC). Embedded within the Centre for Translational Biology, his laboratory focuses on the genetics of aging and neurodegeneration, leveraging the nematode C. elegans to dissect how mitochondrial function, oxidative stress and innate immunity dictate lifespan and resilience. Research Focus: Molecular mechanisms that extend healthy lifespan (geroscience) Mitochondrial signalling pathways (UPR mt , ROS, dynamics) Neuroprotective strategies for Parkinson’s and Huntington’s diseases Translational workflows from worm discoveries to mammalian pre-clinical models His recent publications (2021-2023) converge on the concept that mild mitochondrial stress activates adaptive transcriptional programs—via ATFS-1, DAF-16/FOXO and p38 MAPK—that not only extend life but also protect against proteotoxic stress in neurodegenerative disease models. Exercise, endosomal trafficking proteins and redox systems emerge as modifiable nodes that can recapitulate these benefits. Scientific Awards: No specific honours or awards were detailed in the provided text; citations and h-index metrics (h-index ≈ 45) attest to substantial scholarly impact. Grants & Collaborations: While explicit grant numbers are not listed, his multi-author publications with cross-institutional teams (Harvard, UBC, Northwestern, Emory, etc.) indicate robust national and international funding and collaboration. Laboratory & Teams: Van Raamsdonk heads an active research group within the RI-MUHC Metabolic Disorders and Complications Program; trainees include post-doctoral fellows, graduate students and technicians working on C. elegans genetics, mammalian exercise physiology and high-throughput longevity assays.

• Epidemiology of Aging
• Exceptional Longevity
• Women's Health
• +۷ مورد دیگر

Dr. Aladdin Shadyab is an Associate Professor of Public Health, Human Longevity Science, and Medicine at the University of California San Diego, with a joint appointment in the Herbert Wertheim School of Public Health and Human Longevity Science and the Division of Geriatrics, Gerontology, and Palliative Care, Department of Medicine. He is a leading researcher in the epidemiology of aging and longevity with extensive expertise in multi-omics approaches to studying healthy aging. PhD in Epidemiology, University of California, San Diego (2016) MS in Bioinformatics and Medical Informatics, San Diego State University (2012) MPH in Epidemiology, San Diego State University (2010) BS in Biochemistry, San Diego State University (2008) Dr. Shadyab's research focuses on the epidemiology of aging, exceptional longevity, women's health, geroscience, and multi-omics. His seminal work has identified risk factors for major chronic conditions of aging including cardiovascular disease, diabetes, dementia, hip fracture, and cancer, as well as determinants of exceptional longevity and exceptionally healthy aging. He has made significant contributions to identifying aging biomarkers for healthy aging outcomes. His research on longevity has received national and international recognition in prominent media outlets including TIME, Reuters, The Washington Post, and BBC. Dr. Shadyab's extensive publication record includes over 300 papers in prestigious journals such as JAMA, JAMA Internal Medicine, Alzheimer's & Dementia, and the Journal of the American Geriatrics Society. His work spans multiple domains including genetic epidemiology of longevity, cognitive aging, women's health across the lifespan, dietary influences on aging, and biomarker discovery for age-related conditions. A significant portion of his recent work leverages data from the Women's Health Initiative to examine relationships between biological aging markers, chronic disease risk, and longevity outcomes. Journal of Gerontology: Biological Sciences 2025 Associate Editor Alzheimer's & Dementia 2025 Top Viewed Articles Journal of Gerontology: Medical Sciences 2023 Editor's Choice Manuscript Journal of the American Geriatrics Society 2023 Highest Altmetrics Score Award Longevity.International 2022 Longevity Leader in Research and Academia San Diego State University 2016 Delta Omega Honorary Society in Public Health As Principal Investigator, Dr. Shadyab leads several multi-million-dollar population-based studies focused on examining the role of biological aging in the etiology of Alzheimer's disease and cognitively healthy longevity. He serves as PI on multiple NIA-funded R01s to identify epigenetic and proteomic biomarkers for mild cognitive impairment, Alzheimer's disease, cognitively healthy longevity, and brain aging. He is also an investigator at the Alzheimer's Disease Cooperative Study, participating in randomized controlled trials for Alzheimer's disease. Dr. Shadyab has received numerous research grants totaling several million dollars to support his work on aging and longevity. Dr. Shadyab has played a key leadership role in shaping the strategic planning process for the new Herbert Wertheim School of Public Health and Human Longevity Science at UCSD. He serves in several local and national leadership positions, including as Co-Chair of the Women's Health Initiative COVID-19 Scientific Interest Group and on committees for the Gerontological Society of America. He is recognized as one of the world's leaders in longevity research by Longevity.International.

• Hematopoietic stem-cell biology
• Erythropoiesis
• Mitochondrial metabolism in blood formation
• +۴ مورد دیگر

Saghi Ghaffari, MD, PhD, is Professor of Cell, Developmental & Regenerative Biology and Oncological Sciences at the Icahn School of Medicine at Mount Sinai, New York. She is a member of the Black Family Stem Cell Institute and Tisch Cancer Institute, leads the Ghaffari Lab, and trained in medicine in Paris and doctoral research in Vancouver followed by a clinical-science fellowship at MIT’s Whitehead Institute. Education: MD, Université de Paris XII, Paris, France MSc, Université de Paris XII, Paris, France PhD, University of British Columbia, Vancouver, BC, Canada Clinical Scientist, Whitehead Institute for Biomedical Research, MIT Research Interests: Dr. Ghaffari’s program decodes mechanisms sustaining healthy blood stem and progenitor cells throughout life, with emphasis on metabolic programs governed by mitochondria and lysosomes. Her group investigates how these processes become derailed during aging and in myeloid malignancies, aiming to improve bone-marrow transplantation and to devise metabolic interventions that restore youthful stem-cell function. She pursues questions of hematopoietic stem-cell quiescence, erythroid maturation, oxidative stress signaling, and the intersection of FOXO transcription factors with mTOR and autophagy pathways. Collaborative projects extend from single-cell metabolic profiling to pre-clinical models of β-thalassemia and myeloproliferative neoplasms. Publication Trends 2019-2024: Recent work highlights mitochondrial control of erythropoiesis, lysosomal rejuvenation of aged hematopoietic stem cells, and the unexpected limitation of p21 deletion in β-thalassemic erythropoiesis. COVID-19-related studies linked mild anemia and red-cell distribution width to mortality, underscoring her breadth from basic metabolism to population health. Scientific Honors & Awards: American Society of Hematology Bridge Grant Award (2015) MPN Foundation New Investigator Award (2011) Roche Foundation for Anemia Research Award (2008) Irma Hirschl/Weill-Caulier Trust Research Award (2008) NIH Clinician Scientist Career Award – NCI (1998) American Cancer Society Research Scholar (1998) Terry Fox Physician-Scientist Fellowship, NCIC (1991) Funding & Collaborations: Her laboratory is supported by multiple NIH and foundation grants and maintains active collaborations across Mount Sinai and external institutions. Projects are open to PhD and MD/PhD trainees, with emphasis on interdisciplinary training in stem-cell metabolism, advanced imaging, and translational hematology. Lab & Teams: The Ghaffari Lab (https://labs.icahn.mssm.edu/ghaffarilab) resides on the 13th floor of the Icahn (East) Building, providing state-of-the-art facilities for metabolic flux analysis, single-cell transcriptomics, and in vivo transplantation assays. The group participates in the Cancer Biology and Development, Regeneration & Stem Cells multi-disciplinary training areas at Mount Sinai.

Kenneth Chiouمشاهده پروفایل

استادیار

• Evolution
• Genomics
• Biology of Aging
• +۳ مورد دیگر

Kenneth Chiou is an Assistant Professor in the Department of Biology at the University of Alabama at Birmingham (UAB), within the College of Arts and Sciences. His research focuses on the intersection of sociality, ecology, genomics, and health in primates. He holds a B.A. in Anthropology from New York University, and M.A. and Ph.D. in Physical Anthropology from Washington University in St. Louis. Chiou's work investigates how social experiences, environmental stimuli, and genome evolution influence health and aging in primates. His research employs a multidisciplinary approach, combining field observations, lab experiments, and computational analysis. Key topics include the biological underpinnings of health disparities, evolutionary mechanisms shaping physiology, and the role of social bonds in primate societies. He has conducted fieldwork in diverse locations such as Puerto Rico, Ecuador, Ethiopia, Zambia, and across the U.S. His studies often integrate genomics with ecological and behavioral data, addressing questions like how social environments modulate immune responses and how genetic variation contributes to aging. Notable projects include analyzing microbiome diversity in wild primates and studying SIV infection impacts on gene expression in macaques. Chiou collaborates across disciplines, bridging evolutionary biology, anthropology, neuroscience, and geroscience. His lab focuses on creating comprehensive genomic and transcriptomic resources for primates, including single-cell atlases of the rhesus macaque brain. He emphasizes translational research with implications for human health and aging.

Anne B Newmanمشاهده پروفایل

استاد

• Cardiovascular Epidemiology
• Aging
• Geriatrics
• +۵ مورد دیگر

Dr. Anne B Newman is a Professor of Epidemiology at the University of Pittsburgh, with secondary appointments in Medicine and Clinical and Translational Science. She serves as Director of the Center for Aging and Population Health and Clinical Director of the Aging Institute (University of Pittsburgh/UPMC). Her work focuses on subclinical cardiovascular disease, sarcopenia, and healthy aging, contributing to large-scale studies like the Cardiovascular Health Study (CHS) and Health ABC. Education BS in Biology, University of Pittsburgh (1978) MD, University of Pittsburgh (1982) MPH in Public Health, University of Pittsburgh (1987) As a cardiovascular epidemiologist, her research established links between subclinical cardiovascular disease and aging-related disability/mortality. She expanded this work to include brain MRI changes, peripheral artery disease, and coronary artery calcium. Her Health ABC study findings redefined sarcopenia by showing muscle strength (not mass) predicts mortality. Her recent publications include developing a vigor-to-frailty continuum scale (2024) and contributions to clinical trials like the LIFE Study (2014), ASPREE trial (2018), and the ongoing RIGHT Trial. These studies address mobility interventions, disability-free survival, and inflammation reduction in aging populations. She has led longitudinal cohort studies such as the Long Life Family Study (LLFS) and pioneered the Healthy Aging Index for genetic research and clinical trials. Her affiliations include the University of Pittsburgh's Aging Institute and Center for Aging and Population Health.

Audrey Rupleمشاهده پروفایل

دانشیار

• One Health
• Veterinary Epidemiology
• Comparative Biomedical Sciences
• +۳ مورد دیگر

Audrey Ruple, DVM, MS, PhD, DACVPM, MRCVS, is an Associate Professor in Quantitative Epidemiology at the Department of Population Health Sciences, Virginia-Maryland College of Veterinary Medicine, Virginia Tech. She also serves as the Metcalf Professor of Veterinary Medical Informatics and Program Director of the Biomedical and Veterinary Sciences Graduate Program. Her research focuses on One Health, the intersection of human, animal, and environmental health, with a particular emphasis on cancer and aging in companion dogs as models for improving human and animal health outcomes. Dr. Ruple has held academic positions at Purdue University (2015–2021) before joining Virginia Tech in 2021. Education includes a PhD in Cell and Molecular Biology (2014) and DVM (2008) from Colorado State University, alongside an MS in Epidemiology (2011) and BS in Microbiology (2002). Board-certified by the American College of Veterinary Preventive Medicine (2013) and a member of the Royal College of Veterinary Surgeons, she actively contributes to professional organizations like the American College of Veterinary Preventive Medicine and the American College of Epidemiology. Her research integrates epidemiological methods and One Health principles to address complex health challenges. Notable work includes the Dog Aging Project, a large-scale initiative leveraging canine models to study aging mechanisms and environmental health impacts. Key areas include cancer biology, environmental contaminant exposure, and the role of diet and lifestyle in canine health. Dr. Ruple’s publications emphasize predictive modeling using veterinary data to inform human public health strategies and advancing evidence-based veterinary practices. Professional memberships span veterinary epidemiology, public health, and cancer research organizations. Her academic leadership includes roles in graduate program direction and cross-disciplinary initiatives bridging animal and human health research.

• Genetics and Disease
• Ageing
• Extracellular Matrix Disorders
• +۷ مورد دیگر

Dr Paul Potter is a Senior Lecturer and Group Leader in Disease Mechanisms and Ageing at the School of Biological and Medical Sciences, Oxford Brookes University. He is a Fellow of the Royal Society of Biology and a member of the Centre for Osteoarthritis Pathogenesis at the Kennedy Institute, Oxford. His work integrates genetics, ageing biology, and translational medicine to uncover the molecular underpinnings of chronic and age-related diseases. Education & Training: BSc, ARCS, PhD Post-doctoral training at Imperial College London, Guy’s Hospital, and Hammersmith Hospital Former Head of Disease Model Discovery at the MRC Mammalian Genetics Unit, Harwell Research Interests: Dr Potter’s research focuses on the genetic basis of chronic and age-related diseases , with a particular emphasis on extracellular matrix (ECM) dysfunction , renal disease , osteoarthritis , and cardiomyopathy . He leads the Harwell Ageing Screen , a large-scale phenotype-driven mutagenesis program that identifies novel genes and pathways contributing to disease. His lab uses mouse models to study collagenopathies, mitochondrial disorders, and metabolic dysregulation, aiming to identify therapeutic targets for age-related pathologies. Scientific Contributions & Trends: Across more than 30 peer-reviewed publications since 2015, Dr Potter has consistently explored the intersection of genetics, ageing, and disease modelling . His work spans nephrology , cardiology , neuroscience , and musculoskeletal biology . A recurring theme is the use of ENU mutagenesis and CRISPR/Cas9 to generate novel mouse models that recapitulate human disease, followed by deep phenotyping and molecular profiling to uncover mechanistic insights. Awards & Memberships: Fellow, Royal Society of Biology (FRSB) Member, Centre for Osteoarthritis Pathogenesis, Kennedy Institute, Oxford Member, Society for Experimental Biology and Medicine Editorial Board Member, Experimental Biology and Medicine Supervision & Grants: Dr Potter has supervised numerous PhD and MSc students, including projects on collagen dysfunction in osteoarthritis, renal disease models, mitochondrial cardiomyopathy, and hypoxia signalling in otitis media. He has secured funding from INFRAFRONTIER H2020 , EU COST Actions , and other transnational access programs. Labs & Collaborations: He leads the Disease Mechanisms and Ageing Group at Oxford Brookes and collaborates extensively with the Kennedy Institute , Imperial College London , and the MRC Harwell Institute . His work is supported by shared ageing research infrastructures like ShARM and EUMODIC .

Emily Brayمشاهده پروفایل

استادیار

• Canine Cognition
• Developmental Psychology
• Veterinary Behavioral Science
• +۴ مورد دیگر

Emily Bray is an Assistant Professor in Psychology at the University of Arizona College of Veterinary Medicine and a Faculty Affiliate in Cognition & Neural Systems. Her research focuses on canine cognition, behavior, and the interplay between developmental, genetic, and environmental factors. She leads the BRAY (Behavioral Research Across Years) Lab, which collaborates with institutions like Canine Companions, the Dog Aging Project, and the ManyDogs Consortium. Her work explores: early maternal care's impact on dog cognition and life outcomes; genetic bases of individual differences in dog behavior; age-related cognitive decline; and traits of successful working dogs. Recent studies include the Pets Promoting Positive Mental Wellbeing (PAWS) initiative, the Dog Cognitive Development Battery (DCDB), and the ManyDogs international replication projects. The BRAY Lab's research is funded by organizations including the National Institutes of Health, National Science Foundation, and Mars Waltham. She investigates topics such as oxytocin and cortisol's role in puppy behavior, the effects of physical activity on aging dogs, and machine learning models for predicting service dog success.

Kilian Huberمشاهده پروفایل

دانشیار

• Chemical Biology
• Drug Discovery
• Proteomics
• +۵ مورد دیگر

Kilian Huber is an Associate Professor and Senior Group Leader at the University of Oxford , jointly based at the Nuffield Department of Medicine and its Centre for Medicines Discovery . He also leads the Huber Laboratory within the ChemBioHub and Target Discovery Institute (TDI) , where he pioneers chemical-biology approaches to discover and validate new drug targets. Education & Career: Current: Associate Professor, University of Oxford Group Leader, Centre for Medicines Discovery & Target Discovery Institute Research Interests: Dr Huber integrates chemistry, structural biology, proteomics and functional genomics to create potent and selective chemical probes that illuminate the role of proteins in disease. His laboratory is renowned for: Protein kinase structural biology – having solved >60 novel kinase crystal structures. Epigenetic reader domains – developing first-in-class inhibitors for bromodomains that recognise acetyl-lysine marks. Chemical proteomics – employing chemoproteomics and thermal-stability profiling to map cellular targets of small molecules in native proteomes. High-throughput technologies – including NanoBRET target-engagement assays, AlphaScreen, BLI, ITC and fragment-based crystallography. Research Themes & Technologies: Current efforts span cancer, neurodegeneration, inflammatory disorders and viral infections , with particular emphasis on: Structure-guided design of selective kinase and epigenetic inhibitors. Systems-level phenomic and chemoproteomic screening to uncover novel biology. Open-science initiatives such as the EUbOPEN consortium that aims to deliver chemical probes for the entire human proteome by 2035. Collaborations & Resources: The Huber group operates state-of-the-art platforms for high-throughput crystallography, chemical library screening and target deconvolution in close partnership with the Structural Genomics Consortium , ARUK Oxford Drug Discovery Institute and multiple industry partners. Recent Publications Snapshot: Work published in 2024-2025 addresses anti-ageing effects of bisphosphonates, ALS drug-repurposing strategies, circadian-immune pathway modulation via BMAL1, kinase inhibitor selectivity, SARS-CoV-2 antivirals, and open-access chemical probe generation, reflecting a vibrant pipeline from fundamental discovery toward translational impact.

• Exercise Physiology
• Sports Science
• Metabolism
• +۳ مورد دیگر

Cecilie Moe Weinreich serves as an Academic employee and Guest Researcher in the Department of Biomedical Sciences at the University of Copenhagen's Faculty of Health and Medical Sciences. She is affiliated with the Clemmensen Group focusing on exercise and muscle physiology, based at Blegdamsvej 3B, Mærsk Tårnet, 6th floor, Copenhagen. Her research centers on Exercise Physiology , Sports Science , and Metabolic Health , with specific expertise in Aging Research , Obesity Interventions , and Inflammation Mechanisms . She investigates clinical applications of resistance training, polyphenol supplementation, and pharmacological agents like salbutamol in human performance and metabolic outcomes. Recent publications reveal a strong emphasis on sex-specific physiological responses and randomized controlled trials targeting aging populations and obesity. Her work bridges exercise science with clinical gerontology and metabolic disease management, often examining biomarkers of inflammation and cardiorespiratory fitness. She actively collaborates within the Clemmensen Group on projects involving lifestyle interventions, VO2 peak analysis, and endurance training adaptations, contributing to high-impact publications in journals like GeroScience and International Journal of Obesity.

Colin Farrellyمشاهده پروفایل

استاد

• Political Philosophy
• Bioethics
• Practical Ethics
• +۵ مورد دیگر

Colin Farrelly is the Sir Edward Peacock Professor of Political Theory at Queen's University, cross-appointed with the Department of Philosophy and occasionally teaching in the School of Policy Studies. He holds a PhD from the University of Bristol, along with degrees from McMaster University. His research focuses on political philosophy, bioethics, and the ethics of biomedical advancements, particularly in aging and geroscience. Farrelly has held academic positions globally, including at Oxford, UCLA, and Waterloo University. His work integrates normative theory with empirical insights from biology, demography, and medicine, emphasizing the Enlightenment's ideals of reason and progress. Education: B.A. in Political Studies, Philosophy from McMaster University M.A. in Political Studies, Philosophy from McMaster University Ph.D. in Political Theory from the University of Bristol Research Interests: Farrelly's interdisciplinary work spans political theory, bioethics, and the societal implications of longevity science. Key topics include geroscience (healthy aging), climate geroscience, virtue ethics, and justice in genomic contexts. He advocates for 'positive biology' to refocus medical sciences on healthspan extension and critiques 'folkbiology' in public health discourse. Recent Articles: Recent publications address intersections of aging, climate science, and ethical policy. He emphasizes the societal and ethical dimensions of longevity research, arguing for science that prioritizes human well-being over disease-focused paradigms. Labs/Teams: Collaborates with global networks in geroscience and biomedical ethics, though no specific lab is named. His work often involves interdisciplinary teams across philosophy, medicine, and policy.